Drug intelligence / Profile preview

FungiFoam

Development stage
Unknown
Lead developer
Tetra Corporation
Modality
Small Molecules
Administration
Topical
01

Overview

FungiFoam is an over-the-counter topical antifungal foam developed and marketed by Tetra Corporation. Its active ingredient is tolnaftate at a 1% concentration, a well-established antifungal agent. The product features a unique delivery system where oil-soluble tolnaftate is dissolved in natural jojoba oil, which facilitates rapid skin absorption and direct delivery of the medication to infected areas. FungiFoam is indicated for the treatment and prevention of athlete's foot (tinea pedis) and ringworm (tinea corporis), providing relief from symptoms such as itching, scaling, cracking, redness, and burning. It is marketed as a four-in-one product that combines antifungal treatment with anti-pruritic, moisturizing, and exfoliating properties. The product is primarily dispensed through physician offices and is designed for daily use to prevent the recurrence of fungal infections.

Brand names
FungiFoam
Other names
tolnaftate
02

Targets

SQLE (Squalene monooxygenase)

Beyond the preview

Go deeper on FungiFoam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FungiFoam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call